Imaginis.net launches new T-scan breast cancer diagnostic web site
Imaginis.net launches new T-scan breast cancer diagnostic web site
A Healthcare InfoTech Staff Report
Imaginis.net (Durham, NC) has launched a new, comprehensive web resource (www.imaginis.net/t-scan) detailing the new T-scan breast imaging procedure that has just been FDA-approved.
"T-scan imaging is one of the most important innovations in breast cancer diagnosis in the last 25 years," said Shawl Lobree, editor of Imaginis.net’s breast cancer web site. "We felt it important to provide women with detailed information about this significant development in the fight against breast cancer," she said.
To detect breast cancer, T-scan imaging measures the way electrical current passes differently through normal breast tissue and through cancerous tissue. It is a non-invasive technology used, not as first-line diagnosis, but as a way of better evaluating a mammogram which has indicated suspicious areas in the breast.
The T-scan system does not use radiation and has been called the first new technology for this type of work since approval of magnetic resonance imaging in 1984.
The Imaginis.net web site on T-scan breast imaging includes the following information:
Why T-scan imaging performed; imaging benefits; T-scan imaging; how T-scan breast imaging works; clinical examples of T-scan imaging; answers to frequently asked questions about T-scan imaging; and clinical trial data.
Imaginis.net provides consumers and healthcare professionals with information resources detailing the prevention, diagnosis and treatment of prevalent medical conditions such as breast cancer, heart disease, osteoporosis, sports injuries, stroke and others.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.